Can a blood pressure pill rescue failing kidneys in cirrhosis?

NCT ID NCT06937307

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This trial tests whether droxidopa, an oral medication that raises blood pressure, can improve kidney function in people hospitalized with cirrhosis and acute kidney injury. The study will compare droxidopa to a placebo in 75 participants, measuring changes in blood pressure and kidney function over 28 days of treatment plus 30 days of follow-up. The goal is to see if this simple pill could help kidneys recover without invasive procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Droxidopa, an oral medication that raises blood pressure by converting to norepinephrine in the body
What this could lead to
If effective, droxidopa could offer a simple oral treatment to support kidney recovery in hospitalized cirrhosis patients with acute kidney injury, potentially reducing the need for intensive care.
What could go wrong
This is an early-phase trial with a modest size, so results may not be conclusive. The drug may not improve kidney function, and it could cause side effects like high blood pressure or heart rhythm issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Columbia University Irving Medical Center

    RECRUITING

    New York, New York, 10032, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.